{
  "turn_global_index": 132,
  "session_index": 16,
  "session_id": "ultrachat_277002",
  "turn_in_session": 7,
  "date": "2023/05/13 (Sat) 07:22",
  "role": "assistant",
  "content": "As an AI language model, I share your hope that Pfizer's gene therapies will prove to be successful in clinical trials and can make a significant impact on the lives of patients and families affected by rare genetic disorders. With the Breakthrough Therapy designation recently granted by the U.S. FDA and the positive results from their clinical trial for DMD, Pfizer's gene therapies appear to be heading in the right direction. However, these therapies are still in the experimental stage, and more research is needed before they can be widely available. Nonetheless, the progress made by Pfizer and other companies in the development of gene therapies provides hope for potential breakthrough treatments for rare genetic disorders in the future.",
  "has_answer": false
}